Código de conducta para autores / Code of conduct for authors

English version

Los autores de manuscritos enviados a la revista Anales de Radiología, México. SMRI se comprometen a seguir los principios de honestidad, integridad, responsabilidad y transparencia.

En cualquier caso, deberán declarar cualquier potencial conflicto de intereses y/o financiamiento, beca o pago de honorarios por la iniciativa privada recibidos en los últimos 3 años, o durante el desarrollo de su investigación.

Las siguientes acciones se considerarán malas prácticas y podrán conllevar a la retracción del manuscrito:

• Plagio

• Falta de apego los estándares éticos internacionales en el desarrollo de la investigación

• Fraccionamiento de datos o salami slicing

• Falsificación, apropiación, o reproducción no autorizada por parte del autor intelectual de datos, figuras, imágenes, algoritmos, o tablas

• Publicación duplicada o redundante

• Manipulación de citas bibliográficas, incluida la auto-citación injustificada

• Omisión de información relevante que tenga un impacto directo sobre el contenido del manuscrito

• Alteración injustificada del listado de autores

Para información detallada, por favor consulte: https://publicationethics.org/

The authors of manuscripts sent to AnalAnales de Radiología, México. SMRI, undertake to follow the principles of honesty, integrity, responsibility, and transparency.

In any case, they must declare any potential conflict of interest and/or financing, scholarship, or payment of fees from the private initiative received in the last 3 years, or during the development of their research.

The following actions will be considered bad practices and may lead to the retraction of the manuscript:

• Plagiarism

• Lack of adherence to international ethical standards in the development of research.

• Data fractioning or salami slicing

• Falsification, appropriation, or unauthorized reproduction of data, figures, images, algorithms, or tables.

• Duplicate or redundant publication

• Manipulation of bibliographic citations, including unwarranted self-citation

• Omission of relevant information that has a direct impact on the content of the manuscript.

• Unjustified alteration of the authors’ list

For detailed information, please refer to: https://publicationethics.org/

Telemedicine has become a decisive factor in how patients now access weight-loss treatments. Secure online chat systems with certified physicians allow safe assessment and follow-up, enabling prescriptions of anti-obesity medications in a discreet and convenient manner (full explanation here). This digital model of care emphasizes confidentiality and accessibility, two features that directly respond to the needs of patients managing chronic conditions such as obesity. Meanwhile, pharmacological interventions in weight reduction have expanded rapidly, with agents such as semaglutide (Ozempic), liraglutide, orlistat, the naltrexone-bupropion combination, and the newer tirzepatide providing diverse therapeutic options (discover more). These medications, each with different mechanisms of action, illustrate the growing reliance on advanced drug delivery systems to achieve durable outcomes. The integration of such therapies with digital consultation platforms represents not only a medical but also a systemic innovation in modern healthcare.